'Covaxin' - 427 News Result(s)
- India News | NDTV | Friday August 5, 2022Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
www.ndtv.com
- India News | Reported by Parimal Kumar, Edited by Aarish Chhabra | Friday June 17, 2022Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
www.ndtv.com
- India News | Press Trust of India | Wednesday June 15, 2022The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
www.ndtv.com
- India News | Press Trust of India | Tuesday May 24, 2022The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
www.ndtv.com
- India News | Press Trust of India | Tuesday May 10, 2022CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a "variant-proof" SARS-CoV-2 vaccine candidate.
www.ndtv.com
- Education | Reported by Press Trust of India | Monday May 2, 2022In his letter to the prime minister, Congress leader Adhir Ranjan Chowdhury claimed that there is a lack of availability of Covaxin and Covishield, and most children below 18 years remain unprotected
www.ndtv.com/education
- India News | Asian News International | Friday April 29, 2022Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
www.ndtv.com
- India News | Press Trust of India | Thursday April 28, 2022Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
www.ndtv.com
- India News | Press Trust of India | Tuesday April 26, 2022Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
www.ndtv.com
- India News | Reported by Parimal Kumar, Edited by Aditi Gautam | Tuesday April 26, 2022The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
www.ndtv.com
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal | Thursday April 21, 2022Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
www.ndtv.com
- Delhi News | Press Trust of India | Sunday April 10, 2022Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
www.ndtv.com
- India News | Written by J Sam Daniel Stalin | Sunday April 10, 2022Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
www.ndtv.com
- India News | Edited by Akhil Kumar | Saturday April 9, 2022Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
www.ndtv.com
- India News | Press Trust of India | Saturday April 9, 2022A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
www.ndtv.com
'Covaxin' - 426 Video Result(s)
'Covaxin' - 2 Web Stories Result(s)
'Covaxin' - 427 News Result(s)
- India News | NDTV | Friday August 5, 2022Bharat Biotech on Friday said Japan has approved Covaxin booster dosage for travellers visiting the country.
www.ndtv.com
- India News | Reported by Parimal Kumar, Edited by Aarish Chhabra | Friday June 17, 2022Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
www.ndtv.com
- India News | Press Trust of India | Wednesday June 15, 2022The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
www.ndtv.com
- India News | Press Trust of India | Tuesday May 24, 2022The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
www.ndtv.com
- India News | Press Trust of India | Tuesday May 10, 2022CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a "variant-proof" SARS-CoV-2 vaccine candidate.
www.ndtv.com
- Education | Reported by Press Trust of India | Monday May 2, 2022In his letter to the prime minister, Congress leader Adhir Ranjan Chowdhury claimed that there is a lack of availability of Covaxin and Covishield, and most children below 18 years remain unprotected
www.ndtv.com/education
- India News | Asian News International | Friday April 29, 2022Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
www.ndtv.com
- India News | Press Trust of India | Thursday April 28, 2022Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
www.ndtv.com
- India News | Press Trust of India | Tuesday April 26, 2022Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
www.ndtv.com
- India News | Reported by Parimal Kumar, Edited by Aditi Gautam | Tuesday April 26, 2022The Drugs Controller General of India (DCGI) today gave emergency use authorisation to Bharat Biotech's Covaxin for children between the age group of 6-12 amid an uptick in the Covid cases in schools.
www.ndtv.com
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal | Thursday April 21, 2022Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
www.ndtv.com
- Delhi News | Press Trust of India | Sunday April 10, 2022Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
www.ndtv.com
- India News | Written by J Sam Daniel Stalin | Sunday April 10, 2022Private hospitals in Tamil Nadu have not slashed the prices of Covid vaccines -- Covishield ad Covaxin -- even though the government has announced a massive reduction.
www.ndtv.com
- India News | Edited by Akhil Kumar | Saturday April 9, 2022Serum Institute of India CEO Adar Poonawalla and Bharat Biotech cofounder Suchitra Ella today said that the decision was taken after discussions with the Centre.
www.ndtv.com
- India News | Press Trust of India | Saturday April 9, 2022A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
www.ndtv.com